Editorial Board
Ivette Suarrez Arroyo PhD
Universidad Central del Caribe, School of Medicine, Puerto Rico, United States · Puerto Rico
Editorial leadership for Journal of Breast Cancer Survival
Research interests
- Breast Cancer Biology&Nbsp; Cancer Molecular Markers Metastasis Egfr Trafficking
Selected publications
- ​Medicines Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer.
- The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease.
- Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression.
- Abstract B20: Combination of Ganoderma lucidum extract and erlotinib decreases IBC progression.
- PO133 DIFFERENTIAL EXPRESSION OF PLASMA MEMBRANE PROTEINS IN INFLAMMATORY BREAST CANCER VIA STABLE ISOTOPE LABELED AMINO ACIDS IN CULTURE (SILAC).
- Abstract 5556: Enhancing response of Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells.
- Abstract 3219: Synergistic effect between Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells.
- Abstract 3212: Ganoderma lucidum (Reishi) chemosensitizes EGFR-overexpressing inflammatory breast cancer cells to erlotinib.
- Abstract 2247: Ganoderma lucidum (Reishi) downregulates key proteins overexpressed in IBC and chemosensitizes EGFR-overexpressing cells to erlotinib.
- Abstract 1672: Ganoderma lucidum (Reishi) induces autophagy in inflammatory breast cancer cells to promote cell death.
- Anti-Tumor Effects of Ganoderma lucidum (Reishi) in Inflammatory Breast Cancer in In Vivo and In Vitro Models.
- Abstract 1987: Ganoderma lucidum (Reishi) suppresses key protein synthesis initiation molecules in inflammatory breast cancer.
- Abstract 1992: Ganoderma lucidum (Reishi) induces autophagy in inflammatory breast cancer by regulation of the mTOR signaling pathway.
Considering JBCS for your work?
This journal is guided by Ivette Suarrez Arroyo (Universidad Central del Caribe, School of Medicine, Puerto Rico, United States) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.